Evidence map›Paper›PMID 37086046›Full record

ArticleEuropean journal of immunology2023

Clonally expanded PD-1-expressing T cells are enriched in synovial fluid of juvenile idiopathic arthritis patients.

Anna Vanni, Alessio Mazzoni, Roberto Semeraro, Manuela Capone, Patrick Maschmeyer, Giulia Lamacchia, Lorenzo Salvati, Alberto Carnasciali, Parham Farahvachi, Teresa Giani and 10 more

Open access · hybridAbstract readComment
PubMed Publisher
In one paragraph

Article in European journal of immunology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
3.2field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

20 authors at 8 institutions in 3 countries.

Anna VanniDepartment of Experimental and Clinical Medicine, University of Florence, Florence, Tuscany, Italy.
Alessio MazzoniDepartment of Experimental and Clinical Medicine, University of Florence, Florence, Tuscany, Italy.
Roberto SemeraroDepartment of Experimental and Clinical Medicine, University of Florence, Florence, Tuscany, Italy.
Manuela CaponeDepartment of Experimental and Clinical Medicine, University of Florence, Florence, Tuscany, Italy.
Patrick MaschmeyerInstitute of Health (BIH) at Charité, Universitätsmedizin Berlin, Berlin, Berlin, Germany.
Giulia LamacchiaDepartment of Experimental and Clinical Medicine, University of Florence, Florence, Tuscany, Italy.
Lorenzo SalvatiDepartment of Experimental and Clinical Medicine, University of Florence, Florence, Tuscany, Italy.ORCID 0000-0001-5831-0392
Alberto CarnascialiDepartment of Experimental and Clinical Medicine, University of Florence, Florence, Tuscany, Italy.
Parham FarahvachiDepartment of Experimental and Clinical Medicine, University of Florence, Florence, Tuscany, Italy.
Teresa GianiAOU Meyer, Florence, Tuscany, Italy.
Gabriele SimoniniAOU Meyer, Florence, Tuscany, Italy.
Giovanni FilocamoPediatric Rheumatology, Fondazione IRCCS Cà Granda Ospedale Maggiore Policlinico, Milano IT and University of Milan, Milan, Lombardy, Italy.
Micol RomanoUniversity of Western Ontario, London, Ontario, Canada.
Francesco LiottaDepartment of Experimental and Clinical Medicine, University of Florence, Florence, Tuscany, Italy.
Mir-Farzin MashreghiDeutsches Rheuma-Forschungszentrum (DRFZ), Institute of the Leibniz Association, Berlin, Berlin, Germany.ORCID 0000-0002-8015-6907
Lorenzo CosmiDepartment of Experimental and Clinical Medicine, University of Florence, Florence, Tuscany, Italy.ORCID 0000-0002-8150-8177
Rolando CimazDepartment of Clinical Sciences and Community Health, Research Center for Adult and Pediatric Rheumatic Diseases, University of Milan, Milan, Lombardy, Italy.
Alberto MagiDepartment of Information Engineering, University of Florence, Florence, Tuscany, Italy.
Laura MaggiDepartment of Experimental and Clinical Medicine, University of Florence, Florence, Tuscany, Italy.
Francesco AnnunziatoDepartment of Experimental and Clinical Medicine, University of Florence, Florence, Tuscany, Italy.ORCID 0000-0001-8798-7589
University of Florence · ITAzienda Ospedaliero-Universitaria Careggi · ITMeyer Children's Hospital · ITUniversity of Milan · ITLeibniz Association · DEMax Delbrück Center · DENew York University Florence · ITWestern University · CA

Funding

Department of Experimental and Clinical Medicine of University of Florence
6 · The paper itself

Abstract

Juvenile idiopathic arthritis (JIA) is the most common chronic rheumatic condition in childhood. The disease etiology remains largely unknown; however, a key role in JIA pathogenesis is surely mediated by T cells. T-lymphocytes activity is controlled via signals, known as immune checkpoints. Delivering an inhibitory signal or blocking a stimulatory signal to achieve immune suppression is critical in autoimmune diseases. However, the role of immune checkpoints in chronic inflammation and autoimmunity must still be deciphered. In this study, we investigated at the single-cell level the feature of T cells in JIA chronic inflammation, both at the transcriptome level via single-cell RNA sequencing and at the protein level by flow cytometry. We found that despite the heterogeneity in the composition of synovial CD4

Indexed as

Arthritis, JuvenileCD4-Positive T-LymphocytesCD8-Positive T-LymphocytesHumansInflammationProgrammed Cell Death 1 ReceptorSynovial FluidProgrammed Cell Death 1 ReceptorImmune checkpoints ⋅ Inflammation ⋅ Juvenile Idiopathic Arthritis ⋅ T cells ⋅ PD-1

Identifiers

PMID37086046
OpenAlexW4366742991

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.